Chutko L S, Surushkina S Yu, Anisimova T I
N. Bekhtereva Human Brain Research Institute, Russian Academy of Science, St. Petersburg, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2):81-84. doi: 10.17116/jnevro20171172181-84.
To study anxiety in adolescents with attention deficit hyperactivity disorder (ADHD) and their mothers and to evaluate the efficacy of a dyad approach (simultaneous treatment of the mother and the child) to ADHD treatment.
Thirty-four adolescents, aged 12-15 years, with ADHD and their mothers were studied. All participants of the study received anxiolytic treatment: children were treated with noophen (500 mg per day 45 days) and their mothers received adaptol (1500 mg per day 45 days). In the comparison group with the same clinical/psychological characteristics, anxiolytic therapy with noophen was used only in adolescents.
Symptoms of anxiety were found in 61.7% of adolescents with ADHD and in 79.4% of the mothers. After the dyad therapy, an improvement was noted in 73.5% of adolescents and 69.7% of the mothers. There was an improvement in 63.3% of patients in the comparison group.
The results demonstrate the high efficacy of the dyad approach in treatment of ADHD with comorbid anxiety disorders.
研究注意缺陷多动障碍(ADHD)青少年及其母亲的焦虑情况,并评估针对ADHD治疗的二元治疗方法(同时治疗母亲和孩子)的疗效。
对34名年龄在12至15岁的患有ADHD的青少年及其母亲进行了研究。该研究的所有参与者均接受了抗焦虑治疗:儿童接受诺芬(每天500毫克,共45天)治疗,其母亲接受阿得尔托(每天1500毫克,共45天)治疗。在具有相同临床/心理特征的对照组中,仅对青少年使用诺芬进行抗焦虑治疗。
在患有ADHD的青少年中,61.7%存在焦虑症状,在母亲中这一比例为79.4%。经过二元治疗后,73.5%的青少年和69.7%的母亲病情有所改善。对照组中63.3%的患者病情有改善。
结果表明二元治疗方法在治疗伴有共病焦虑症的ADHD方面具有很高的疗效。